SERIOUS
(G)
Actual Harm - a resident was hurt due to facility failures
Pressure Ulcer Prevention
(Tag F0686)
A resident was harmed · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and record review, the facility did not ensure that Residents without a Pressure Injury (PI) do not develop p...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and record review, the facility did not ensure that Residents without a Pressure Injury (PI) do not develop pressure injuries, and receive appropriate care, treatment, & preventative measures to promote healing for 1 (R9) of 3 Residents reviewed for pressure injuries.
* R9 was admitted to the facility on [DATE] with diagnoses which included a right hip fracture. The admission body check documents a 3.0 x 1.8 cm (centimeter) purple area that is not open potentially indicating the presence of a DTI (deep tissue injury).
The wound assessment 8/9/22 documents a Stage 2 PI with 90% slough & 10% epithelial tissue. R9's pressure injury was not staged correctly as a Stage 2 pressure injury does not include slough.
The 8/17/22 wound assessment continues to stage R9's pressure injury as a Stage 2 with 100% granulation tissue. R9's pressure injury was staged incorrectly as a Stage 2 doesn't contain granulation tissue.
On 8/18/22 R9's skin integrity care plan was revised.
The wound assessment dated [DATE] staged the PI as Unstageable with the wound bed being 100% slough. There were no revisions to R9's care plan after 8/18/22.
On 8/25/22 the nurses note documents NP (Nurse Practitioner) updated per facility policy for an order for a wound culture.
The wound specimen from coccyx collected on 8/25/22 and verified on 8/30/22 documents pseudomonas aeruginosa & mixed aerobic flora.
On 8/30/22 during treatment change, the dressing was completely saturated with a foul odor. An order was received on 8/30/22 for Cipro 500 mg twice daily for 7 days.
The wound assessment dated [DATE] documents Stage 4 with 50% granulation, 50% slough, and exposed bone. There was no revision to R9's care plan.
On 10/27/22, R9's pressure injury had an increase in drainage with the drainage being described as cloudy tan serosanguineous and a slight odor. A wound culture and sensitivity were ordered.
On 10/30/22, lab results revealed MRSA (Methicillin-resistant Staphylococcus aureus) in R9's pressure injury and an antibiotic was again ordered. On 10/31/22, a second antibiotic was ordered.
R9's wheelchair & recliner cushion and mattress as observed by Surveyor are not appropriate for a Stage 4 pressure injury.
Findings include:
The facility policy and procedure last revised on 8/19 titled: Prevention and Care of Pressure Injuries indicates under policy: All residents that are at risk for developing a pressure injury will have preventative measure implemented to prevent and or aid in the healing of pressure injuries.
Under Pressure Injury Grading System for Stage II (2) documents Partial thickness loss of dermis presenting as a shallow open ulcer with red of sic (or) pink wound bed, without slough. May also present as an intact or open/ruptured blister. This stage should not be used to describe perineal dermatitis, maceration, or excoriation.
Under recommendations for treatment and care for Stage III (3) and Stage IV (4) documents
Desired outcome: Promote healing and reduce bacterial growth, evaluate, and monitor. All recommendations per MD (medical doctor) order.
1. Keep wound clean by using Wound Cleanser or normal saline.
2. Reduce bacterial growth: Local Infection - (edema, pus, erythema, exudates, etc.) Topical anti-microbial therapy if applicable. Systemic infection - (chills, fever, elevated WBC (white blood count)) obtain order for culture and/or antibiotic therapy, if applicable.
3. Adequate nutritional intake, ongoing consultation with Dietician.
4. Assure a low-pressure environment - pressure reducing mattress,
R9 was admitted to the facility on [DATE] with diagnoses including right hip fracture, HTN (hypertension), and chronic congestive heart failure.
The hospital Discharge summary dated [DATE] includes documentation for skin indicating: no evidence of rash or excoriations.
Review of the undated and unsigned admission body check includes a circle at the coccyx area on the diagram with documentation of 3.0 cm (centimeter) x 1.8 cm purple without open area. The description on this admission body check would indicate R9 has a potential DTI (deep tissue injury).
The nurses note dated 8/9/22 documents Patient is A&O x4 (alert and orientated times four) with periods of forgetfulness. Is able to make her needs known. Is very HOH (hard of hearing). Wears Bil (bilateral) hearing aids which does not seem to help. Transfers with 1A (one assist) [NAME] steady. Denies pain upon this assessment. VSS (vital signs stable), HRR (heart rate regular), no abnormal sounds noted. No cough or SOB (shortness of breath) noted. LSCTA (lung sounds clear to auscultation). Abd (abdomen) soft n/t (non-tender) with BS (bowel sounds) x4. Scattered bruising to BUE (bilateral upper extremities). Abrasion to her R (right) elbow and coccyx with treatment done. Protective cream applied to coccyx. Continent of B&B (bowel and bladder) with clear yellow urine noted. NP (non pitting) edema noted to BLE (bilateral lower extremities). Is on a general NAS (no added salt) diet. Surgical dressing to R (right) hip with small amount of drainage noted. Area outlined to monitor. Call light and pendent within reach.
The wound assessment dated [DATE] documents Stage II (2), location not identified. Measurements are 4 cm x 2.3 cm, exudate is light serosanguineous and wound bed is 90% slough & 10% epithelial tissue. For wound edges/margins the assessment documents Edge attached to base; Irregular wound edges; Macerated soft. Under comments documents, Area was cleansed with wound cleanser, hydrogel applied to wound bed, skin prep to peri wound and covered with an Optifoam dressing. Minimal amount of drainage noted. Surveyor noted R9's pressure injury was incorrectly staged, as a Stage 2 pressure injury does not have slough and PI should have been staged as Unstageable. Surveyor also noted the documentation on what R9's skin conditions were upon admission has conflicting information on what R9's coccyx condition was on admission.
The APNP (Advance Practice Nurse Prescriber) rehab admission note dated 8/11/22 does not include documentation of R9's pressure injury.
On 8/11/22, the coccyx treatment for hydrogel, skin prep, and Optifoam was discontinued, and a new treatment was ordered to cleanse the wound with wound cleanser or soap & water, pat dry, and apply Chymosin barrier cream twice a day & prn (as needed).
The Alteration in skin integrity care plan with a start date of 8/11/22 & last reviewed/revised on 10/27/22 documents the following approaches:
* Equagel cushion to be in place where I am sitting in recliner or wheelchair. Start date of 8/11/22.
* SKIN: Help turn/reposition every 2 hours. Side to side when in bed with pillow support. Start date of 8/11/22.
* Follow Standard of Care Protocol for Skin Care. Start date of 8/11/22 & discontinued on 10/13/22.
The Standard of care protocol for skin has approaches of:
Complete a body check on all admissions, readmissions, and before and after ER (emergency room) visits/hospitalizations.
Complete a Braden Scale upon admission/readmission and every week for three weeks thereafter, quarterly, and change of condition.
Thorough skin inspection to be done weekly during bath by the nurse who should fill out a skin audit observation after the bath.
A standard pressure relief cushion should be in the chair and a standard pressure relief mattress on the bed.
Should keep skin clean and dry.
Should apply moisture barrier cream after resident has an incontinent episode.
Apply sunscreen, sunglasses, and hat with a brim, if it's anticipated that there could be prolonged exposure to the sun.
Follow basic good skin care which includes washing, rinsing, and dry thoroughly should be provided to residents requiring assistance with personal hygiene.
Be aware of any allergies or sensitive skin when ordering lubricants or creams.
Reposition residents with pillows behind the back and between the legs. Avoid positioning directly on the hip bone.
Off load resident's heels in bed.
If braces, casts, or splints are used, daily skin checks should be done to monitor for s/s (signs/symptoms) skin breakdown.
Weekly measurements of all wounds (surgical wounds, pressure ulcers, skin tears, venous stasis ulcers, abrasions, lacerations, etc.) should be done until healed. The measurements and progress should be documented.
The Dietitian and WCC/RN (Wound Care Certified/Registered Nurse) should be updated if a resident has a Stage 1 or greater ulcer for dietary interventions and wound treatment.
The resident's physician and family or POA-HC (power of attorney health care) should be updated on skin integrity.
Treatments should be according to the physician's order.
A referral to the Wound Clinic for consult as needed.
* SKIN: Please move the Equagel cushion to the recliner or wheelchair. Start date of 8/18/22.
Surveyor noted there are no revisions to R9's skin integrity care plan after 8/18/22.
The wound assessment dated [DATE] documents Stage II (2). Measurements are 3.2 cm x 1.5 cm x 0.1 cm, exudate is light serous and wound bed is 100% epithelial tissue. For wound edges/margins the assessment documents Edge attached to base; Irregular wound edges.
The nurses note dated 8/11/22 documents Right elbow skin tear almost healed, no longer needs a dressing. Tx (treatment) changed to apply skin prep to right elbow BID (twice a day), to leave steri-strip in place. Stage II coccyx wound treatment changed from hydrogel with Optifoam dressing to applying Chamosyn (sic) barrier cream BID and PRN (as needed). NP (Nurse Practitioner) updated per facility policy to wound care dressing treatment changes. To off-load pressure to buttock with repositioning Q2 (every two) hours and turning side to side with pillow support Q2 hours while in bed, Equagel cushion to be in place in recliner or wheelchair when pt (patient) sitting in it. Educations provided to pt about importance off off-loading pressure to buttock area, pt verbalized understanding.
The physician order dated 8/11/22 documents 1 packet Juven BID (twice a day) ok to mix with juice or water and 1 oz (ounce) liquid protein (active) supplement BID ok to mix with Juven. On 8/15/22 the order was changed from BID to QD (every day).
R9's admission MDS (minimum data set) with assessment reference date of 8/16/22 documents a BIMS (brief interview mental status) score of 13 which indicates cognitively intact. R9 is coded as not having any behaviors including refusal of cares. R9 requires limited assistance with one-person physical assist for bed mobility & ambulation, extensive assistance with one-person physical assist for transfer & toilet use, and is independent with set up for eating. R9 is at risk for pressure injuries and is coded as having one Stage 2 pressure injury, present upon admission.
The pressure injury CAA (care area assessment) dated 8/18/22 under analysis of findings documents R9 was admitted with a stage II pressure injury to her coccyx. She also has a skin tear to her right elbow. Treatments are done as ordered. Interventions in place to reduce pressure. According to the hospital Discharge summary dated [DATE], R9 underwent an ORIF (open reduction and internal fixation) of her right hip fracture which was sustained from a fall. Her incision has no s/s (signs/symptoms) of infection. During the seven-day look back period, she was continent of bowel per vitals and occasionally incontinent of bladder per POC (plan of care). Staff assist with incontinence care. Her Braden score was 18. She needs limited assist with bed mobility per POC. A pressure reduction cushion is in the chair, and a standard pressure relief mattress is on the bed. Skin is inspected with cares, and a skin audit is done weekly. The dietician has met with her and completed the nutritional assessments. PT, OT, and ST (physical therapy, occupational therapy, and speech therapy) have done their evaluations (see PT/OT/ST assessments). She is participating in therapies as ordered to regain her strength and endurance and to improve her mobility so she can be more independent with bed mobility, transfers, and ambulation.
The wound assessment dated [DATE] documents Stage II (2). Measurements are 4 cm x 1.5 cm, tissue type is granulation. Surveyor noted R9's pressure injury is incorrectly staged, as a Stage 2 does not have granulation tissue. The pressure injury should have been staged as a Stage 3.
The initial physician visit dated 8/17/22 under review of systems includes documentation of Reports: buttocks pain does have history of previous right superior and inferior pubic rami fractures. Under objective for musculoskeletal documents: Dressing over right lateral hip with just small soiling no tenderness over dressing. There is no documentation or reference regarding R9's coccyx pressure injury.
The wound assessment dated [DATE] documents Stage II (2). Measurements are 4.5 cm x 2 cm, exudate is light serosanguineous and wound bed is 100% epithelial tissue. For wound edges/margins the assessment documents Edge attached to base; Macerated/soft; Well defined wound edges. Under comments it is documented Stage 2 to coccyx is stable. Minimal amount of serosanguineous drainage noted. Treatment order changed to cleanse area with wound cleanser, apply hydrogel to wound bed, cover with Optifoam dressing. QOD (every other day) and PRN (as needed). Writer encouraged patient to utilize wheelchair cushion while sitting in recliner.
R9's skin integrity care plan was revised on 8/18/22 with addition to Please move the Equagel cushion to the recliner or wheelchair. There were no further revisions to R9's skin integrity care plan.
On 8/23/22, the treatment was changed to cleanse wound, apply hydrogel, cover with Optifoam every other day. On 8/26/22 this treatment was changed from every other day to twice daily.
The wound assessment dated [DATE] documents stage as Unstageable Slough and/or Eschar, measurements are 6.5 cm x 6 cm x 0.2 cm, exudate is moderate seropurulent, wound bed is 100% slough, and wound healing status is documented as declining. Surveyor noted there are no revisions to R9's skin integrity care plan.
The nurses note dated 8/25/22 documents Coccyx wound is larger, wound bed covered in slough tissue and is now an Unstageable pressure injury. Drainage is moderate sero-purulent drainage, no odor noted, peri-wound is red, but does blanch. To continue with current dressing change tx and off-loading interventions. NP updated per facility policy for an order for a wound culture.
The wound assessment dated [DATE] documents stage as Unstageable Slough and/or Eschar, measurements are 7.7 cm x 4.4 cm x 2.8 cm, exudate is moderate serous, wound odor is pungent odor, wound bed is 100% slough, wound edges/margins are well defined wound edges, and wound healing status is stable. Under comments documents Slough area detached from R side of wound on R gluteal, exposed 2.8 cm tunneling noted. Treatment order changed per wound nurse recommendations.
On 8/29/22 it is documented in R9's medical record the treatment was changed and indicates it was changed to the Stage 2 coccyx: Cleanse area with wound cleanser, pack tunneled area with Maxorb AG (silver), apply hydrogel slough areas, cover with sacral Optifoam dressing twice a day.
The nurses note dated 8/30/22 documents Patient is A&O x 4 with occasional forgetfulness and confusion. No complaints of pain at time of assessment. Transfers and ambulates with 1A (one assist) using WW (wheeled walker). Heart rate and rhythm regular with murmur. +2 pitting edema to RLE (right lower extremity) and +1 pitting edema to LLE (left lower extremity). Tubigrips applied and BUE elevated when able. Strength is strong and equal with hand grasp and foot press. Unstageable pressure injury to coccyx area which has declined, slough present and tunneling. Treatment done this morning; previous dressing was completely saturated, foul odor present. Call light within reach, safety maintained.
The wound specimen from coccyx collected on 8/25/22 and verified on 8/30/22 documents pseudomonas aeruginosa & mixed aerobic flora.
The nurses note dated 8/30/22 documents NOR (new order received) from APNP for Lasix 20mg (one time), Cipro 500mg BID (twice a day) x7 days, Florastor 250mg BID x10 days, and check BMP (basic metabolic panel) in the morning.
The wound assessment dated [DATE] documents stage as Stage IV (4), measurements are 7.5 cm x 3 cm x 2. cm, exudate is heavy seropurulent, there is no wound odor, wound bed is 50% granulation & 50% slough, wound edges/margins on assessment indicate edge is not attached to base and wound healing status is declining. Under comments documents Undermining 2.0 cm from 2 o'clock-9 o'clock. Slough tissue is lifting. Base of wound granulation tissue with exposed bone.
The nurses note dated 9/1/22 documents Coccyx wound assessed. Wound continues to decline quickly. There is exposed bone at wound base. Wound does appear as a Kennedy ulcer. To continue with current dressing change orders and off-loading interventions. If family agrees to hospice care, goal to be geared towards comfort over wound healing. Surveyor noted there was no documentation that the physician or nurse practitioner were consulted with or notified of this at this time.
The nurses note dated 9/2/22 documents: Patient is A&O x3 (alert and orientated times three) with times of forgetfulness but is able to make her needs known appropriately. VSS (vital signs stable). denies pain unless its during coccyx dressing change. Hand and foot grasps strong and equal. Transfers using 1A (one assist) WW (wheeled walker) and GB (gait belt) and tolerates well. Walks to and from the bathroom and to and from meals. Needs extensive assist with lower ADLs (activities daily living) and dressing. Once set up for grooming she can do that independently. HRR (heart rate regular). Has +1 pitting edema to BLE (bilateral lower extremities), tubi grips are on. Coccyx wound dressing changed this morning and the previous dressing was about half saturated with foul smelling tan colored drainage, the area was cleansed and packed per order. Call light within reach and safety maintained.
On 9/2/22 the treatment remained the same except for instead of covering the pressure injury with a sacral Optifoam dressing, the covering was changed to an Optilock dressing and secure with paper tape. The frequency remained the same at twice a day.
The nurses note dated 9/6/22 documents, Large section of slough/dead tissue has fallen off of wound. Area cleansed and dressing changed.
The social service note dated 9/8/22 documents: Care conference held today, in attendance was resident's daughter (name), son (name), writer, and nursing. Lengthy discussion regarding hospice services and education on their services. Family in agreement with hospice services after discussion with resident and other family members. Resident and family choice for hospice agency is (name.) All questions answered, no concerns at this time.
The nurses note dated 9/8/22 documents: Coccyx wound assessed, measured and dressing change provided. The coccyx wound is stable, wound bed does appear clean, mild odor noted before cleansing, drainage to old dressing seropurulent. Pt (patient) assisted to left side in bed with staff assistance and tolerated dressing change well. To continue with current dressing change tx (treatment) and off-loading interventions.
The wound assessment dated [DATE] documents stage as Stage IV (4), measurements are 6 cm x 6 cm x 2. cm, exudate is moderate purulent, wound odor is mild, wound bed is 80% granulation & 20% slough, wound edges/margins on assessment indicate edge not attached to base and wound healing status is stable. Under comments documents Tunnel at 12 o'clock 4.0 cm, and 1 o'clock 4.5 cm with undermining 2 o'clock-4 o'clock 3.0 cm and 9 o'clock-11 o'clock 1.0 cm.
The note dated 9/12/22 documents, Writer notified by (hospice company) hospice nurse that resident, with her family present, signed onto hospice services this morning. No concerns at this time.
The nurses note dated 9/15/22 documents: Coccyx wound assessed, measured and dressing changed. Wound appears clean with 90% granulation tissue and 10% slough tissue. No odor noted and drainage is moderate serous. Pt tolerated dressing change well. To continue with current dressing change orders and off-loading.
The wound assessment dated [DATE] documents stage as Stage IV (4), measurements are 7.0 cm x 3 cm x 2.5 cm, exudate is moderate serous, there is no wound odor, wound bed is 90% granulation & 10% slough, wound edges/margins indicate edge not attached to base and wound healing status is stable. Under comments documents, Tunnel at 11 o'clock 4.0 cm, and 12 o'clock 3.0 cm with undermining 9 o'clock-10 o'clock 2.0 cm and 1-3 o'clock 2.0 cm.
The significant change MDS with an assessment reference date of 9/21/22 documents a BIMS of 12 which indicates moderately impaired. R9 requires extensive assistance with one-person physical assist for bed mobility, transfer, & toilet use, and requires supervision with set up for eating. R9 is at risk for pressure injuries and is coded as having one Stage 2 pressure injury. Surveyor noted the pressure injury should have been coded as a Stage 4. Surveyor also noted the decline in R9's assessed need for assistance since the admission MDS dated [DATE]. Surveyor noted this decline is not addressed in R9's plan of care.
The Pressure injury CAA dated 9/29/22 under analysis of findings documents R9 was admitted with a stage II pressure injury to her coccyx. Treatments are done as ordered. Interventions in place to reduce pressure. During the seven-day look back period, she was continent of bowel per vitals and frequently incontinent of bladder per POC. Staff provide incontinence care. Her Braden score was 17. A pressure reduction cushion is in the chair, and a standard pressure relief mattress is on the bed. Skin is inspected with cares, and a skin audit is done weekly. The dietician has met with her and completed the nutritional assessments. She is at risk for malnutrition. She has started hospice services due to declining self-care abilities and mobility. Surveyor noted the change in R9's assessed needs for assistance are not reflected in R9's care plan.
The wound assessment dated [DATE] documents stage as Stage IV (4), measurements are 6 cm x 3 cm. There is no depth documented. Exudate is moderate serous, there is no wound odor, wound bed is 90% granulation & 10% slough, wound edges/margins are well defined wound edges and wound healing status is stable. Under comments documents 2.5 cm tunnel from 11 o'clock-1 o'clock, 1.5 cm undermining from 2-4 o'clock and 1.5 cm from 9-10 o'clock.
On 9/22/22 the treatment to the wound bed stayed the same with the covering being changed to a bordered foam sacral dressing or Optilock dressing secured with paper tape. The frequency remained the same at twice a day.
The APNP note dated 9/26/22 under history, present illness includes documentation of: Due to condition with large sacral wound, pt stopped therapy. Discussion with family led to hospice eval with desire for comfort and wound healing Coccyx DTI (deep tissue injury) Open to bone with tunneling. Treated with Cipro x 10 days 8/30/22 due to infection with pseudomonas. It has improved but is still open. Per wound care RN on 9/22 wound is 90% granulation 10% slough without odor and moderate serous drng (drainage).
The wound assessment dated [DATE] documents stage as Stage IV (4), measurements are 6 cm x 3 cm x 0.5 cm. Exudate is moderate serous, there is no wound odor, wound bed is 100% granulation, wound edges/margins are rolled under/thickened and wound healing status is stable. Under comments documents, No discomfort during dressing change. This was completed by a registered nurse.
The wound assessment dated [DATE] documents stage as Stage IV (4), measurements are 5.5 cm x 2.5 cm x 1 cm. Exudate is moderate serous, there is no wound odor, wound bed is 100% granulation, wound edges/margins are well defined wound edges and wound healing status is stable. Under comments documents 4.0 cm tunnel from 11 o'clock, 12 o'clock 2.5 cm tunnel. undermining from 1-4 o'clock and 9-10 o'clock 1.5. This assessment was completed by the facility wound nurse.
The nurses note dated 9/29/22 documents, Coccyx wound assessed, measured and dressing changed. Wound appears clean with 100% granulation tissue. No odor noted and drainage is moderate serous. Pt (patient) tolerated dressing change well. To continue with current dressing change orders and off-loading. Hospice updated to needed wound supplies per facility policy.
On 9/29/22 the treatment for the wound bed and for the dressing covering the coccyx remained the same except the order included: if Maxorb Ag was not available Aquacel rope may be used.
The wound assessment dated [DATE] documents stage as Stage IV (4), measurements are 5.5 cm x 2.5 cm x 1.2 cm. Exudate is moderate serous, there is no wound odor, wound bed is 100% granulation, wound edges/margins are well defined wound edges and wound healing status is stable. Under comments documents 4.0 cm tunnel from 11 o'clock, 3.0 cm at 12 o'clock. Undermining 2.0 cm from 1-3 o'clock and 9-10 o'clock.
The wound assessment dated [DATE] documents stage as Stage IV (4), measurements are 5 cm x 2.5 cm x 1.2 cm. Exudate is moderate serous, there is no wound odor, wound bed is 100% granulation, wound edges/margins are well defined wound edges and wound healing status is improving. Under comments documents 4.0 cm tunnel from 11 o'clock, 2.5 cm at 12 o'clock, 3.0 cm at 9 o'clock. Undermining 1.5 cm from 1-2 o'clock and 10 o'clock.
The physician progress note dated 10/19/22 under HPI (history present illness) documents, Reviewed care with RN Care Coordinator (name.) This is my second visit with her. I had seen her 2 months ago on rehab. She had the right femur fracture. She says it is not really pain but discomfort. She has a (sic) ulcer on her coccyx that (RN Care Coordinator name) says measures 5 x 2.5 x 1.2 in depth she says it is stage IV (4).
The wound assessment dated [DATE] documents stage as Stage IV (4), measurements are 5 cm x 2.5 cm x 1.2 cm. Exudate is moderate serosanguineous, there is no wound odor, wound bed is 100% granulation, wound edges/margins are well defined wound edges and wound healing status is stable. Under comments documents 4.0 cm tunnel at 11 o'clock, 2.0 cm at 12 o'clock, 2.0 cm at 9 o'clock. Undermining 1.5 cm from 1-2 o'clock and 10 o'clock.
The nurses note dated 10/20/22 documents Wound to coccyx area assessed and measured. Wound continues to be stable with no s/sx of infection. Wound is not draining as heavily, tx (treatment) changed from BID to daily. To continue with offloading interventions.
On 10/20/22 the coccyx pressure injury treatment was changed to cleanse area with wound cleanser, gently pack tunneled area with Maxorb AG (may use plain Maxorb or Aquacel/Aquacel ag rope if Maxorb ag supply is not available) apply hydrogel to wound and cover with bordered foam sacral dressing daily and prn (as needed).
The nurses note dated 10/23/22 documents Coccyx wound draining into incontinence pad and somewhat odorous. Contact isolation implemented. Surveyor noted there was no physician notification. Surveyor noted there were no details of a consultation despite indicating the wound was somewhat odorous.
The wound assessment dated [DATE] documents stage as Stage IV (4), measurements are 5 cm x 2.5 cm. There is no depth documented. Exudate is moderate seropurulent, there is no wound odor, wound bed is 100% epithelial tissue, wound edges/margins are Edge attached to base and wound healing status is stable. Surveyor noted this assessment was completed by a Licensed Practical Nurse and there is no indication the physician or nurse practitioner were consulted with.
The wound assessment dated [DATE] documents stage as Stage IV (4), measurements are 5.5 cm x 2 cm x 0.5 cm. Exudate is heavy seropurulent, there is a slight foul odor, wound bed is 100% granulation tissue, wound edges/margins are well defined wound edges and wound healing status is declining. Under comments documents, There is a 1.5 cm x 1.0 cm eschar area to left side of coccyx wound that is communicated with undermining of wound.
The nurses note dated 10/27/22 documents Coccyx wound has increased drainage and has a cloudy tan serosanguineous drainage with increased erythema to peri-wound, slight odor noted. Dressing tx (treatment) changed from daily to BID (twice daily). NP (Nurse Practitioner) updated per facility policy to frequency to dressing changes and of wound observations. Wound culture and sensitivity requested and obtained.
On 10/27/22 the coccyx pressure injury treatment was changed to Cleanse area with wound cleanser, gently pack tunneled area with Maxorb AG (may use plain Maxorb or Aquacel/Aquacel ag rope if Maxorb ag supply is not available) apply hydrogel to wound and cover with bordered foam sacral dressing BID & PRN.
The physician orders dated 10/27/22 documents coccyx wound culture and sensitivity.
The nurses note dated 10/30/22 documents Updated (name,) APNP, on culture with sensitivity. Received order for Doxycycline for 10 days and Florastor for 14 days. POA (power of attorney) for HC (healthcare), here to visit and updated on new orders.
The lab report dated 10/30/22 documents Staphylococcus aureus, methicillin resistant.
The nurses note dated 10/31/22 documents, Resident remains on report to monitor r/t (related to) NOR (new order received) for ABT (antibiotic)/Doxycycline for MRSA (methicillin-resistant staphylococcus aureus) of coccyx wound. No adverse effects noted from ABT use. Skin is warm, dry and color is WNL (within normal limits)/pink. Resident denies pain/discomfort to coccyx area, dressing remains C/D/I. (clean/dry/intact) Temp (temperature) is 97.6
The physician order dated 10/31/22 documents: Add Amoxicillin 500 mg BID x 7 days dx (diagnosis) infection to coccyx wound.
On 10/31/22 at 9:15 a.m., Surveyor observed R9 sitting in a wheelchair with a cushion in her wheelchair and being wheeled by activities staff to a Halloween activity.
On 10/31/22 at 10:35 a.m., Surveyor asked R9 if she has any open areas. R9 replied, yes on my butt but they take care of it. Surveyor asked R9 how she received this area. R9 replied I don't know.
On 10/31/22 at 2:24 p.m., Surveyor observed R9 sitting in a wheelchair in her room with a male visitor sitting next to her.
On 11/1/22 at 7:07 a.m., Surveyor observed R9 sitting in a wheelchair at a dining room table. R9 has a cushion in her chair. R9 was inquiring why she was up so early and indicated she wanted to go back to bed. After observing R9, Surveyor went to R9's room to see if there was a cushion in R9's personal type recliner. Surveyor observed a cushion in the personal type recliner with the cover indicating Invacare floair, and noted there is not a specialized mattress on R9's bed.
On 11/1/22 at 8:31 a.m., Surveyor spoke to CNA (Certified Nursing Assistant) F regarding R9. CNA F informed Surveyor R9 was up early, had a little breakfast, and wanted to go back to bed. Surveyor observed R9 in bed on her right side with her eyes closed. The call light is within R9's reach and R9's heels are not being offloaded.
On 11/1/22 at 9:58 a.m., Surveyor observed R9 in bed on her left side.
On 11/1/22 at 9:59 a.m., Surveyor asked CNA F what time R9 would be getting out of bed. CNA F informed Surveyor they got her up a few minutes ago, took R9 to the toilet, and R9 wanted to go back to bed. CNA F informed Surveyor R9 is usually a one assist for transfers but they had to use a lift to transfer her so R9 must not be feeling good.
On 11/1/22 at 10:46 a.m., Surveyor asked RN/CC (Registered Nurse)/Care Coordinator C if there is a wound team at the Facility. RN/CC C informed Surveyor there is a wound nurse (name) who comes in on Thursdays. Surv
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
PASARR Coordination
(Tag F0644)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and record review, the facility did not refer 1 (R62) of 1 residents reviewed for a Level II PASARR (Preadmis...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and record review, the facility did not refer 1 (R62) of 1 residents reviewed for a Level II PASARR (Preadmission Screen and Resident Review) whom was found to have a newly diagnosed mental illness and prescribed psychotropic medication used to treat the symptoms of the mental illness.
On 4/13/2022 R62 was diagnosed with Generalized Anxiety Disorder and started to receive Depakote and the Zoloft. On 5/11/2022 R62 was diagnosed with Psychotic disorder with delusions due to known physiological condition. On 5/11/2022 R62 began receiving Abilify to treat symptoms. On 7/7/2022 R62 was diagnosed with Alzheimer's disease with late onset and on 10/19/2022 R62 was diagnosed with Dementia in other diseases classified elsewhere, unspecified severity with other behavioral disturbances. The facility had not completed a new level 1 or 2 PASARR screen for R62 until Surveyor inquired about the screen.
Findings include:
The facility policy, entitled Preadmission Screening and Resident Review (PASRR) (sic), dated 7/17/2017, states:
I. Purpose: To identify individuals with mental illness and/or intellectual developmental disability to ensure appropriate placement.
D. If the resident has a change in condition, which affects BIMS (exception: a physical change such as a stroke will not warrant a PASRR) or changes in psychotropic medication, a new PASRR will be completed.
R62 was admitted to the facility on [DATE], and had diagnoses that include displaced fracture of medial condyle of left tibia, subsequent encounter for closed fracture with routine healing, unspecified fracture of lower end of left femur, subsequent encounter for closed fracture with routine healing and chronic kidney disease stage 3 unspecified.
R62's admission MDS (Minimum Data Set) dated, 2/22/2022, indicated that R62's BIMS (Brief Interview of Mental Status) was scored at a 4 indicating severe cognitive impairment. Section I, Active Diagnoses, does not have any check marks for anxiety, psychotic disorder, or Alzheimer's. No check marks under Psychiatric/Mood Disorders or Neurological sections. Section N, Medications, documents no antidepressants or antianxiety medication given over the past 7 days.
R62's Quarterly MDS (Minimum Data Set) dated, 8/25/2022, documents a BIMS score of 3, indicating R62 is severely cognitively impaired. Section I, Active Diagnoses documents Psychotic disorder with delusions due to known physiological condition and anxiety. Section N, Medications, documents antidepressants were given in the past 7 days.
On 10/31/2022, Surveyor review R62's current medications on the Medication Administration Record (MAR). The MAR documents that R62 is currently receiving Depakote 125mg BID (two times per day), Depakote 250mg HS (at bedtime), and Zoloft 100mg HS (at bedtime).
Review of R62's medical record documents an initial PASARR Level I screen dated 2/14/2022. This document that R62 is not suspected of having a serious mental illness or developmental disability. It also documents that R62 has not received psychotropic medications to treat symptoms or behaviors of a major mental disorder in the past six months.
Surveyor could not locate any additional PASARR Level I or Level II screens in R62's chart. Surveyor notes that a new PASARR Level I screen should have been completed when R62 received a diagnosis of Generalized Anxiety Disorder on 4/13/2022 and started to receive Depakote and the Zoloft. Additionally, on 5/11/2022 R62 was diagnosed with Psychotic disorder with delusions due to known physiological condition and began receiving Abilify to treat symptoms. On 7/7/2022 R62 was diagnosed with Alzheimer's disease with late onset and on 10/19/2022 R62 was diagnosed with Dementia in other diseases classified elsewhere, unspecified severity with other behavioral disturbances.
On 11/01/2022, at 9:45 AM, Surveyor requested copies of R62's PASARRS from DON-B.
On 11/01/2022, at 2:24 PM, facility provided a copy of the admission PASARR Level I screen dated 2/14/2022. The DON-B then provided another PASARR Level I screen dated 11/1/2022 and stated that the SW-E (Social Worker) submitted another PASARR Level I today.
On 11/02/2022, at 9:48 AM, Surveyor interviewed SW-E and asked who is responsible to complete PASARR screens. SW-E informed the Surveyor that upon admission typically the director of Social Services completes the admission PASARR and then the unit SW would be responsible to complete any future PASARR screens should a resident need one. Surveyor asked SW-E what would happen if after admission a resident presented with a mental illness and/or stated receiving psychotic medication for behavior or symptoms of a mental illness. SW-E informed Surveyor that a new Level I screen would be completed. Surveyor informed SW-E that a PASARR Level I screen could not be located in R62's chart after receiving new psychotic/mood disorder diagnoses and psychotropic medication which started back in April 2022. SW-E was not sure why one was not completed for R62. SW-E stated, for sure she should have had a new Level I completed when the psychotropic medication was started. SW-E then stated that she did complete a new PASARR Level I screen earlier today.
On 11/2/2022, DON-B, was notified on the concern regarding R62 and missing PASARR screens.
No further information was provided as to why the facility did not refer R62 for a Level II PASARR Screen prior to 11/1/2022.